6533b81ffe1ef96bd127841b
RESEARCH PRODUCT
1281P The prognostic impact of tissue tumour mutational burden (TMB) in the first-line treatment of advanced non-oncogene addicted non-small cell lung cancer (NSCLC): A systematic review and meta-analysis of randomized controlled trials
L. CastellanaSofia CutaiaA. GuariniDaniele FanaleNadia BarracoValerio GristinaLorena IncorvaiaLaura TomaselloMarco BonoClarissa FilorizzoSergio RizzoA. CucinellaA. RussoGiuseppe BadalamentiL. InsalacoAntonio GalvanoMaria Rita RicciardiG. MadoniaViviana BazanG. Militisubject
Oncologymedicine.medical_specialtyOncogenebusiness.industrynon-small cell lung cancer (NSCLC)Hematologymedicine.diseaselaw.inventionFirst line treatmentOncologyRandomized controlled triallawInternal medicineMeta-analysismedicinebusinessyear | journal | country | edition | language |
---|---|---|---|---|
2020-09-01 | Annals of Oncology |